KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS

Patent europeic · EP3533792 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3533792
Numer da la dumonda
EP19169275
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-06-2013
Publitgà
04-09-2019
Concedì
05-05-2021
La protecziun finescha il pli tard
03-06-2033
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07D 401/04 (2006.01)
A61K 31/4439 (2006.01)
A61K 31/4184 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201261656888 P 07.06.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Apalutamid

C03533792/01 · Medicament · Concedì · Protecziun dals 04-06-2033 fin ils 18-09-2034

Admissiun 67072 (Swissmedic, 19-09-2019)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 07-08-2024

    Midada

    Published in Swissreg on 07.08.2024

  4. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  5. 20-12-2023

    Adressa midada

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.12.2023

  6. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  7. 29-08-2022

    Adressa midada

    Owner
    Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, USA, Sloan Kettering Institute For Cancer Research, 1275 York Avenue, New York, NY 10065, USA → Sloan Kettering Institute For Cancer Research, 1275 York Avenue, New York, NY 10065, USA, Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, USA

    Published in Swissreg on 29.08.2022

  8. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

3 endataziuns pli veglias
  1. 16-02-2022

    Midada

    Published in Swissreg on 16.02.2022

  2. 07-05-2021

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 07.05.2021

  3. 05-05-2021

    Concedì

    Published in Swissreg on 05.05.2021

Partidas

Possessur

Sloan-Kettering Institute for Cancer Research

Sloan Kettering Institute For Cancer Research

1275 York Avenue, New York, NY 10065, US

Aragon Pharmaceuticals, Inc.

10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

OUERFELLI, Ouathek

Fort Lee, NJ 07024, US

SMITH, Nicholas D.

San Diego, CA 92109, US

HERBERT, Mark R.

San Diego, CA 92111, US

DILHAS, Anna

4055 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.